Cardiorenal Syndrome
When heart and kidney failure occur together, traditional treatments often fall short. Our nephrology team provides expert volume management, ultrafiltration, and dialysis support for complex cardiorenal patients.
The Heart-Kidney Connection
Cardiorenal syndrome (CRS) describes the interconnected dysfunction of heart and kidneys, where impairment in one organ leads to dysfunction in the other. This bidirectional relationship creates a challenging clinical scenario where standard treatments often worsen one condition while trying to help the other.
The combination is increasingly common: heart failure and chronic kidney disease share risk factors, and each accelerates the progression of the other.
The Vicious Cycle
Types of Cardiorenal Syndrome
Acute heart failure leads to acute kidney injury
Chronic heart failure leads to progressive CKD
Acute kidney injury leads to acute cardiac dysfunction
CKD leads to chronic cardiac disease
Systemic condition (sepsis, diabetes) affects both
The Diuretic Dilemma
When standard heart failure therapy reaches its limits
The Problem
- High-dose diuretics can worsen kidney function
- Diuretic resistance develops in severe heart failure
- Rising creatinine limits diuretic escalation
- Volume overload persists despite maximum medical therapy
Our Solution
- Ultrafiltration for gentle, controlled fluid removal
- CRRT for hemodynamically unstable patients
- Intermittent HD for patients with established ESRD
- Collaborative management with cardiology
Cardiorenal Management Services
Comprehensive nephrology support for heart failure programs
Ultrafiltration
Slow, controlled fluid removal without the electrolyte disturbances of aggressive diuresis. Can remove liters of fluid while preserving hemodynamic stability.
CRRT
24-hour continuous therapy for critically ill cardiorenal patients. Precise hourly fluid targets while maintaining cardiac output.
Volume Assessment
Expert assessment of true volume status. Many patients labeled 'diuretic resistant' actually need different targets or approaches.
Collaborative Care
Daily coordination with cardiology and heart failure teams. Shared decision-making on fluid goals and medication adjustments.
Diuretic Optimization
Sometimes the answer isn't dialysis—it's better diuretic strategy. We help optimize medical therapy before escalating to dialysis.
Transition Planning
Clear communication about when dialysis can stop and medical therapy resume. Not all cardiorenal patients need permanent dialysis.
For Cardiologists & Heart Failure Teams
We understand the goals of heart failure management. Our approach prioritizes preserving cardiac function while addressing volume overload and kidney dysfunction.
- Same-day ultrafiltration availability for acute decompensation
- Coordination around cardiac procedures and device management
- LVAD-compatible dialysis protocols
- Pre-transplant optimization and post-transplant support
- Shared patients with clear communication and care coordination
- Evidence-based approach—ultrafiltration when it helps, not reflexively
When to Consider Nephrology
Urgent
- • Volume overload with respiratory distress despite IV diuretics
- • Rising creatinine limiting diuretic use
- • Refractory hyperkalemia
Consider Early
- • eGFR <30 in heart failure patient
- • Frequent readmissions for volume overload
- • Planning for LVAD or cardiac transplant
Collaborative Management
- • Complex CKD/heart failure patients
- • Medication optimization in renal impairment
- • Long-term dialysis planning
Frequently Asked Questions
Is ultrafiltration better than diuretics for heart failure?
The CARRESS-HF trial showed no clear benefit of ultrafiltration over stepped diuretic therapy in most patients. However, ultrafiltration remains valuable for truly diuretic-resistant patients or those with contraindications to high-dose diuretics. The key is appropriate patient selection.
Should I hold ACE inhibitors when creatinine rises in heart failure?
Not necessarily. A modest creatinine rise (up to 30%) is often acceptable and doesn't mean the medication is harmful. ACE inhibitors and ARBs have proven survival benefits in heart failure. Stopping them may lead to worse long-term outcomes. We can help assess whether the creatinine rise is concerning.
Can patients come off dialysis after cardiorenal syndrome?
Yes, many patients with Type 1 CRS (acute heart failure causing AKI) recover kidney function once cardiac output improves. We monitor closely for recovery and transition patients off dialysis when appropriate. Permanent dialysis is not inevitable.
How do you manage fluid in patients with LVADs?
LVAD patients require careful volume management—both overload and dehydration can cause problems. We work closely with LVAD teams on optimal dry weight and dialysis parameters. CRRT and intermittent HD are both compatible with most LVAD systems.
Partner With Us for Cardiorenal Care
Whether you need urgent ultrafiltration support or want to establish a cardiorenal collaboration for your heart failure program, we're here to help.